| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHOPHT.1997.01100150499009 |
| P698 | PubMed publication ID | 9109759 |
| P2093 | author name string | M Gonzalez | |
| M R Hernandez | |||
| A H Neufeld | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 497-503 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Nitric oxide synthase in the human glaucomatous optic nerve head. | |
| P478 | volume | 115 |
| Q31048568 | A mouse model of elevated intraocular pressure: retina and optic nerve findings |
| Q34644392 | A novel perspective on natural therapeutic approaches in glaucoma therapy |
| Q35762641 | A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model |
| Q36249969 | Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress |
| Q22306304 | Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head |
| Q24306375 | Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy |
| Q36114710 | Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients |
| Q44930300 | Altered expression of nNOS/NIDD in the retina of a glaucoma model of DBA/2J mice and the intervention by nNOS inhibition |
| Q33383024 | Ameliorative effect of PN-277 on laser-induced retinal damage |
| Q45926332 | Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. |
| Q36924168 | Association of Common Variants in eNOS Gene with Primary Open Angle Glaucoma: A Meta-Analysis |
| Q33586390 | Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts |
| Q34493805 | Association of genetic polymorphisms of eNOS with glaucoma. |
| Q38077464 | Autocrine and paracrine interactions and neuroprotection in glaucoma |
| Q44580601 | Beta-adrenergic receptor agonists and antagonists counteract LPS-induced neuronal death in retinal cultures by different mechanisms |
| Q34317963 | Blood flow in the optic nerve head and factors that may influence it. |
| Q42588146 | Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma |
| Q37811029 | Clinical and experimental links between diabetes and glaucoma |
| Q41221957 | Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice |
| Q27007111 | Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases |
| Q38345428 | DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure |
| Q43087162 | Degenerative effects in rat eyes after experimental ocular hypertension |
| Q49925827 | Delta Opioids: Neuroprotective Roles in Preclinical Studies |
| Q35997726 | Diabetes mellitus as a risk factor for glaucomatous optic neuropathy |
| Q34066154 | Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis |
| Q44387186 | Differences in nitric oxide production: a comparison of retinal ganglion cells and retinal glial cells cultured under hypoxic conditions |
| Q40905133 | Differential expression of neural cell adhesion molecule isoforms in normal and glaucomatous human optic nerve heads |
| Q35114509 | Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma. |
| Q30729740 | Effect of isosorbide mononitrate on the human optic nerve and choroidal circulations. |
| Q37195549 | Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina |
| Q46921488 | Endothelin-1, nitric oxide, and glutamate in the normal and glaucomatous dog eye. |
| Q53563049 | Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma. |
| Q37230041 | Friend or foe? Resolving the impact of glial responses in glaucoma |
| Q51639287 | Functional and Structural Evaluation of Sildenafil in a Rat Model of Acute Retinal Ischemia/Reperfusion Injury. |
| Q33697351 | Functional role of nitric oxide in regulation of ocular blood flow |
| Q24673200 | Ganglion cell death in glaucoma: what do we really know? |
| Q33361962 | Gene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors |
| Q38091321 | Glaucoma and optic nerve repair. |
| Q41455152 | Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis |
| Q27011820 | Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha |
| Q35609009 | Glaucomatous optic neuropathy: when glia misbehave |
| Q41243838 | Glutathione attenuates nitric oxide-induced retinal lipid and protein changes |
| Q90206205 | Immune Mediated Degeneration and Possible Protection in Glaucoma |
| Q36811368 | Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma |
| Q43592546 | In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head |
| Q92025393 | Increased Optic Nerve Head Capillary Blood Flow in Early Primary Open-Angle Glaucoma |
| Q73258549 | Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells |
| Q39210271 | Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria |
| Q33311386 | Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model |
| Q36440373 | Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma |
| Q82164007 | Investigation of nitric oxide in pterygium |
| Q36833382 | Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma |
| Q33811789 | Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study |
| Q34565476 | Ischemic model of optic nerve injury |
| Q45111328 | Mechanisms of neuroprotection against glaucoma |
| Q37759230 | Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis |
| Q93088329 | Microglia in Retinal Degeneration |
| Q93137688 | Microvascular endothelial function and primary open angle glaucoma |
| Q46311561 | Model systems for experimental studies: retinal ganglion cells in culture |
| Q34976640 | Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection |
| Q41997847 | Neurodegenerative diseases of the retina and potential for protection and recovery |
| Q73399989 | Neuroprotection as a Treatment for Glaucoma: Pharmacological and Immunological Approaches |
| Q24245944 | Neuroprotection for prevention and treatment of glaucoma in adults |
| Q24200657 | Neuroprotection for treatment of glaucoma in adults |
| Q24240024 | Neuroprotection for treatment of glaucoma in adults |
| Q30238789 | Neuroprotection for treatment of glaucoma in adults. |
| Q26740388 | Neuroprotection in Glaucoma |
| Q60476041 | Neuroprotection in glaucoma |
| Q35704053 | Neuroprotection in ophthalmology: a review |
| Q90692702 | Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead |
| Q43732143 | Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure |
| Q38384978 | Neuroprotective therapies for glaucoma. |
| Q34264114 | New horizons in neuroprotection |
| Q35592096 | Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma |
| Q73265161 | Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability |
| Q24306235 | Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol |
| Q43850078 | Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve |
| Q74340328 | Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats |
| Q33693579 | Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma |
| Q35944015 | Optic nerve and neuroprotection strategies |
| Q30865527 | Optic nerve blood flow in glaucoma |
| Q34057614 | Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage |
| Q48875855 | Oxidative stress and glaucoma: injury in the anterior segment of the eye. |
| Q24654000 | Oxygen and blood flow: players in the pathogenesis of glaucoma |
| Q37779827 | Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma |
| Q49382584 | Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. |
| Q36770323 | Pharmacological neuroprotection for glaucoma |
| Q33693551 | Physiology of perfusion as it relates to the optic nerve head |
| Q35174032 | Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage |
| Q78030149 | Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma |
| Q50458445 | Primary open-angle glaucoma and systemic diseases |
| Q36379509 | Protective effects of melatonin in experimental free radical-related ocular diseases. |
| Q26861763 | Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma |
| Q35704136 | Regulation of nitric oxide and soluble guanylyl cyclase |
| Q34362259 | Regulation of nitric oxide production by δ-opioid receptors during glaucomatous injury |
| Q34264108 | Relevance of the site of injury of glaucoma to neuroprotective strategies |
| Q34490926 | Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin |
| Q34808624 | Retinal ganglion cell disorders: types and treatments |
| Q27334415 | Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens |
| Q35174023 | Retinal ganglion cells and neuroprotection for glaucoma |
| Q38149325 | Rho-kinase inhibitors offer a new approach in the treatment of glaucoma |
| Q53647549 | S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model. |
| Q33903298 | Saving the nerve from glaucoma: memantine to caspaces |
| Q54324076 | Serum levels and H/L gene polymorphism of mannose-binding lectin in primary open angle glaucoma. |
| Q55346905 | Severity of primary open-angle glaucoma in patients with hypertension and diabetes. |
| Q28393364 | Short-Term Moderately Elevated Intraocular Pressure Is Associated With Elevated Scotopic Electroretinogram Responses |
| Q27331498 | Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma |
| Q34313669 | Structure-function relations of parasol cells in the normal and glaucomatous primate retina |
| Q35496394 | Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice |
| Q88805962 | Targets of Neuroprotection in Glaucoma |
| Q97528932 | The Neurovascular Unit in Glaucomatous Neurodegeneration |
| Q38902036 | The Role of Magnesium in the Pathogenesis and Treatment of Glaucoma |
| Q39449147 | The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma |
| Q88557586 | The nitric oxide-guanylate cyclase pathway and glaucoma |
| Q33882462 | The optic nerve head in glaucoma: role of astrocytes in tissue remodeling |
| Q38101684 | The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge |
| Q92320484 | The relationship between glutathione levels in leukocytes and ocular clinical parameters in glaucoma |
| Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
| Q37958629 | The role of TGF-β in the pathogenesis of primary open-angle glaucoma. |
| Q37831387 | The role of blood pressure in glaucoma |
| Q49192854 | The role of microglia in the progression of glaucomatous neurodegeneration- a review |
| Q34264156 | Three common assumptions about ocular blood flow and glaucoma |
| Q58389051 | Un vaccin contre le glaucome, mythe ou réalité ? |
| Q77170547 | What's new in ophthalmic surgery |
| Q36051597 | YC-1 targeting of hypoxia-inducible factor-1α reduces RGC-5 cell viability and inhibits cell proliferation |
Search more.